Professor Aloj research is focussed on the novel applications of radiolabelled pharmaceuticals for the study and treatment of cancer with contributions spanning from basic preclinical radiopharmaceutical development and mechanistic studies, to novel clinical applications in nuclear medicine diagnostics and therapy.
